Skip to main content
Maki Yamamoto, MD, General Surgery, Orange, CA

Maki Yamamoto MD

General Surgery•Orange, CA

Endocrine, Melanoma, Surgical Oncology (Other than Breast)

Physician

Join to View Full Profile

  • 101 The City Dr SOrange, CA 92868

  • Phone+1 714-456-8000

  • Fax+1 714-456-7244

Dr. Yamamoto is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Yamamoto's Full ProfileAlready have an account?

Education & Training

  • University of South Florida Morsani/Moffitt Cancer Center
    University of South Florida Morsani/Moffitt Cancer CenterFellowship, Complex General Surgical Oncology, 2011 - 2014
  • University of California (Irvine)
    University of California (Irvine)Residency, Surgery, 2004 - 2011
  • New York Medical College
    New York Medical CollegeClass of 2004

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2006 - 2026
  • FL State Medical License
    FL State Medical License 2011 - 2019
  • Surgery
    American Board of Surgery Surgery
  • Complex General Surgical Oncology
    American Board of Surgery Complex General Surgical Oncology

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

Press Mentions

  • Prospective, Multicenter Study Demonstrates That DecisionDx®-Melanoma Test Results Can Significantly Reduce the Number of Sentinel Lymph Node Biopsy (SLNB) Procedures Performed When Used Within the Context of Current Guidelines
    Prospective, Multicenter Study Demonstrates That DecisionDx®-Melanoma Test Results Can Significantly Reduce the Number of Sentinel Lymph Node Biopsy (SLNB) Procedures Performed When Used Within the Context of Current GuidelinesFebruary 9th, 2023
  • -Melanoma Test Results Can Significantly Reduce the Number of Sentinel Lymph Node Biopsy (SLNB) Procedures Performed When Used Within the Context of Current Guidelines
    -Melanoma Test Results Can Significantly Reduce the Number of Sentinel Lymph Node Biopsy (SLNB) Procedures Performed When Used Within the Context of Current GuidelinesFebruary 9th, 2023

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Maki Yamamoto, Dr. Maki Yamamoto, MD, Dr. M Yamamoto